HHS Price Forum: Surprisingly Good Context For Pharma Ideas For Regulatory Changes
This article was originally published in RPM Report
The Obama Administration’s public forum to discuss responses to high drug prices sounded like a major threat to innovator companies. But it provided a setting to press for changes in marketing regulation sought by industry for years.
Register for our free email digests: